Richard Albang

10 total papers · 2.1k total citations
2 papers, 23 citations indexed

About

Richard Albang is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Richard Albang has authored 2 papers receiving a total of 23 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Genetics and 0 papers in Infectious Diseases. Recurrent topics in Richard Albang's work include Polyamine Metabolism and Applications (2 papers), Animal Genetics and Reproduction (2 papers) and Cancer-related gene regulation (1 paper). Richard Albang is often cited by papers focused on Polyamine Metabolism and Applications (2 papers), Animal Genetics and Reproduction (2 papers) and Cancer-related gene regulation (1 paper). Richard Albang collaborates with scholars based in Germany. Richard Albang's co-authors include Г. Брем, Walter H. Günzburg, Brian Salmons and Andreas F. Kolb and has published in prestigious journals such as Biochemical and Biophysical Research Communications and Journal of Cellular Biochemistry.

In The Last Decade

Richard Albang

2 papers receiving 20 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Richard Albang 18 17 4 2 2 2 23
Arveen Kamath 22 1.2× 18 1.1× 6 1.5× 2 1.0× 1 0.5× 4 32
Juliann McConnell 14 0.8× 21 1.2× 6 1.5× 1 0.5× 2 31
F. C. Sauer 19 1.1× 18 1.1× 3 0.8× 1 0.5× 4 28
Stephen Hellens 21 1.2× 10 0.6× 3 0.8× 1 0.5× 4 32
Marie‐Line Jacquemont 17 0.9× 13 0.8× 8 2.0× 2 29
Ira Lu 11 0.6× 10 0.6× 7 1.8× 2 1.0× 1 0.5× 3 16
A Paunovic 18 1.0× 12 0.7× 2 0.5× 4 20
Elena Frolova 8 0.4× 10 0.6× 4 1.0× 2 1.0× 3 1.5× 3 21
Samuel H. Zinner 20 1.1× 17 1.0× 8 2.0× 1 0.5× 1 0.5× 2 33
Nada Derar 14 0.8× 19 1.1× 2 0.5× 1 0.5× 3 26

Countries citing papers authored by Richard Albang

Since Specialization
Citations

This map shows the geographic impact of Richard Albang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Albang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Albang more than expected).

Fields of papers citing papers by Richard Albang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Albang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Albang. The network helps show where Richard Albang may publish in the future.

Co-authorship network of co-authors of Richard Albang

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Albang. A scholar is included among the top collaborators of Richard Albang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Albang. Richard Albang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026